Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-07-07 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Parties | TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 6,414,126; 6,515,117; 7,943,582; 8,513,202 | ||
| Attorneys | AARON SCOTT ECKENTHAL | ||
| Firms | Budd Larner, PC | ||
| Link to Docket | External link to docket | ||
Details for MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 0000-00-00 | 1 | JP) 6,414,126 B1 7/2002 Ellsworth et a1. …characteristics, is characterized by its 6,414,126 B1 7/2002 Ellsworth et al. …United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively…collectively, the “Patents-in- suit”) under the patent laws of the United States, 35 U.S.C. §100, et seq. This… THE PATENTS-IN-SUIT 11. On May 17, 2011, the United States Patent and Trademark | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
